Skip to main content
. 2019 Jun 30;11(2):79–84. doi: 10.15171/jcvtr.2019.15

Table 2. Co-morbidities and electrolytes imbalance of patients with chronic heart failure (n=200) .

Co-morbidities HFrEF (n=150) HFpEF (n=38) HFmrEF (n=12)
Anemia 112 (74.6%) 6 (15.7%) 2 (16.6%)
Hypertension 32 (21%) 28 (73.6%) 4 (33.3%)
Coronary artery disease 48 (32%) 10(26.3%) 2 (16.6%)
Type 2 diabetes mellitus 31(20.6%) 9 (23.6%) 0
Chronic kidney disease 16 (10.6%) 4 (10.5%) 0
Hypothyroidism 9 (6%) 1 (2.6%) 0
Chronic obstructive pulmonary disease 10(6.6%) - -
Stroke 6 (4%) - -
Hyperthyroidism 3(2%) - -
Pulmonary embolism 3 (2%) - -
Electrolytes imbalance
Hyponatremia (<135 mEp/L)
Hypernatremia (>145 mEq/L)
Hypokalemia (< 3.5 mEq/L)
Hyperkalemia (> 5 mEq/L)

58(38.6%)
14(9.3%)
11(7.3%)
16(10.6%)

4 (10.5%)
-
4 (10.5%)
2 (5.2%)

-
-
1 (8.3%)
-

Abbreviations: HFrEF: heart failure with reduced ejection fraction; HFpEF: heart failure with preserved ejection fraction, HFmrEF: heart failure with a mid-range ejection fraction.